Physician profile
John Raper
NPI 1902423155
$3,432.60
in general payments reported to CMS, 2019-2025
33 companies · $1,183 in 2025
The $1,183 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $42.22 · 2021: $304 · 2022: $106 · 2023: $547 · 2024: $1,250 · 2025: $1,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,833 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,833.10 |
| Education | $146.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $511.95 | 2024-2025 | Impella |
| Cvrx, INC. | $296.14 | 2023-2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $263.27 | 2023-2025 | Camzyos, Eliquis |
| United Therapeutics Corporation | $221.50 | 2023-2025 | Tyvaso, Tyvaso |
| Novo Nordisk INC | $215.07 | 2024-2025 | Wegovy |
| Amgen INC. | $213.48 | 2024-2025 | Repatha |
| Pfizer INC. | $198.50 | 2020-2025 | |
| Boston Scientific Corporation | $170.44 | 2023-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd |
| Astrazeneca Pharmaceuticals Lp | $159.02 | 2020-2023 | Wainua |
| Esperion Therapeutics, INC. | $150.38 | 2024-2025 | Nexletol, Nexlizet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.48 | 2023-2025 | Jardiance, Ofev |
| Janssen Pharmaceuticals, INC | $112.26 | 2021-2024 | Xarelto |
| Abbott Laboratories | $96.40 | 2025 | Ensite |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.11 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $59.12 | 2023 | Verquvo |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $57.83 | 2025 | Indigo System |
| Chiesi USA, INC. | $50.43 | 2025 | Kengreal, Cleviprex |
| Abbvie INC. | $50.01 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $50.00 | 2025 | Gore-Tex Vascular Graft |
| Lexicon Pharmaceuticals, INC. | $49.21 | 2024 | |
| La Jolla Pharmaceutical Company | $41.71 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.70 | 2022 | |
| Heartflow, INC. | $28.30 | 2025 | |
| Novartis Pharmaceuticals Corporation | $23.57 | 2021 | |
| Alnylam Pharmaceuticals INC. | $22.84 | 2025 | Amvuttra |
| Gilead Sciences, INC. | $21.21 | 2021 | |
| Bridgebio Pharma, INC. | $19.97 | 2025 | Attruby |
| Grifols USA, LLC | $19.34 | 2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $18.61 | 2023 | Wakix |
| Medtronic, INC. | $16.73 | 2025 | Aurora Ev-Icd Mri Surescan |
| Mylan Specialty L.P. | $15.50 | 2023 | Yupelri |
| Edwards Lifesciences Corporation | $13.78 | 2021 | |
| Allergan, INC. | $13.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Raper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.